Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2015 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SYNAPTICS INC | 24 | Q3 2023 | 7.3% |
TECHNOLOGY SELECT SECT SPDR | 24 | Q3 2023 | 5.7% |
SPRINT CORPORATION | 24 | Q3 2023 | 5.1% |
VANGUARD INDEX FDS | 24 | Q3 2023 | 6.2% |
WAVE LIFE SCIENCES LTD | 24 | Q3 2023 | 8.2% |
ORMAT TECHNOLOGIES INC | 24 | Q3 2023 | 6.8% |
SOLAREDGE TECHNOLOGIES INC | 24 | Q3 2023 | 4.5% |
SEI INVESTMENTS CO | 24 | Q3 2023 | 3.4% |
SWITCH INC | 24 | Q3 2023 | 3.6% |
FIRST TRUST US EQUITY OPPORT | 24 | Q3 2023 | 2.1% |
View MEITAV INVESTMENT HOUSE LTD's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CollPlant Biotechnologies Ltd | July 24, 2023 | 492,619 | 5.0% |
Finnovate Acquisition Corp.Sold out | May 24, 2023 | 0 | 0.0% |
PARTNER COMMUNICATIONS CO LTD | January 11, 2023 | 15,704,244 | 8.4% |
Intec Pharma Ltd. | November 04, 2020 | 120,816 | 3.1% |
KAMADA LTD | February 18, 2020 | 2,090,149 | 5.0% |
Anchiano Therapeutics Ltd. | November 18, 2019 | 1,806,577 | 4.9% |
Itamar Medical Ltd. | September 12, 2019 | 16,058,196 | 4.8% |
Can-Fite BioPharma Ltd. | May 13, 2019 | 1,908,756 | 3.5% |
Foresight Autonomous Holdings Ltd. | March 20, 2019 | 7 | 4.6% |
B COMMUNICATIONS LTD | January 15, 2019 | 499 | 5.0% |
View MEITAV INVESTMENT HOUSE LTD's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-05-06 |
13F-HR | 2024-05-01 |
SC 13G/A | 2024-03-25 |
13F-HR | 2024-01-29 |
SC 13G/A | 2024-01-09 |
SC 13G/A | 2024-01-09 |
13F-HR | 2023-10-30 |
SC 13G/A | 2023-08-17 |
13F-HR/A | 2023-08-10 |
SC 13G/A | 2023-08-07 |
View MEITAV INVESTMENT HOUSE LTD's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.